Results 41 to 50 of about 9,739 (219)

Equine Coital Exanthema: New Insights on the Knowledge and Leading Perspectives for Treatment and Prevention [PDF]

open access: yes, 2021
Equine coital exanthema (ECE) is a highly contagious, venereally-transmitted mucocutaneous disease, characterized by the formation of papules, vesicles, pustules and ulcers on the external genital organs of mares and stallions, and caused by equid ...
María Edith Barrandeguy   +5 more
core   +1 more source

Circumocular Exanthema Associated with Chronic Rejection after Kidney Transplantation

open access: yes, 2010
A 43-year-old man had severe circumocular exanthema associated with chronic rejection 10 years after receiving a kidney transplant to treat end-stage renal failure.
Takahisa Kobayashi   +4 more
core   +1 more source

Transcriptomic signatures reveal systemic adaptations and immune modulation in response to training and competitive racing in horses

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background The molecular mechanisms underlying adaptation to physical exertion and racing stress in horses remain incompletely understood. Peripheral blood transcriptomics offers a minimally invasive method to monitor systemic responses to exercise and identify biomarkers of adaptation or overload. Objectives To evaluate transcriptomic changes
Izabela Dąbrowska   +4 more
wiley   +1 more source

Management of Treatment Resistant EGFR Inhibitor‐Induced Papulopustular Exanthema With Isotretinoin and Dapsone

open access: yesAustralasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Epidermal growth factor receptor inhibitors (EGFRi) commonly cause papulopustular exanthemas that may compromise the success of cancer therapy. While tetracyclines are first‐line treatment, data on alternative systemic agents for refractory cases remain limited.
Ishana Dixit   +2 more
wiley   +1 more source

Características de pacientes con Zika atendidos en el policlínico “Dr. Gustavo Aldereguía Lima”, Las Tunas

open access: yesRevista Electrónica Dr. Zoilo E. Marinello Vidaurreta, 2020
Fundamento: en el policlínico “Dr. Gustavo Aldereguía Lima” se notificaron casos de Zika que presentaron diferencias respecto a lo que más abunda en la literatura.Objetivo: caracterizar a los pacientes con Zika residentes del área geográfica que abarca ...
Leandro Jorge Riverón-Cruzata   +1 more
doaj  

HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema [PDF]

open access: yes, 2021
To characterize human leukocyte antigen (HLA) loci as risk factors in aromatic antiepileptic drug-induced maculopapular exanthema (AED-MPE). A case-control study was performed to investigate HLA loci involved in AED-MPE in a southern Han Chinese ...
Mao, BJ   +23 more
core   +1 more source

Development of Betalactam‐Predictor: A Clinical Decision Tool for Delabeling Low‐Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy

open access: yesAllergy, EarlyView.
BL‐Predictor has emerged as a new tool for delabeling penicillin allergy. External validation has shown a specificity of 93% for detecting low‐risk patients. This score could potentially reduce diagnostic costs and the negative consequences associated with incorrect antibiotic allergy labels.
Marina Labella   +14 more
wiley   +1 more source

Hypersensitivity to Excipients in Drugs: An EAACI Position Paper

open access: yesAllergy, EarlyView.
ABSTRACT Drugs contain active pharmaceutical ingredients and excipients, compounds which enhance the pharmacokinetics, stability and palatability of the pharmaceutical formulation. While most drug hypersensitivity reactions (DHR) are caused by active ingredients, excipients may also be involved.
Lene H. Garvey   +10 more
wiley   +1 more source

About exanthema subitum in children

open access: yes, 2018
The article describes etiopathogenesis, clinical picture, diagnosis, management and prognosis of exanthema subitum (ES). The disease occurs in nearly all infants and is not well-known in the general medical community.
V.S. Androukh
core   +1 more source

Home - About - Disclaimer - Privacy